Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review.
Authors
Iqbal, JGinsburg, O
Wijeratne, T
Howell, Anthony
Evans, D Gareth R
Evans, D Gareth R
Sestak, I
Narod, S
Affiliation
Women's College Research Institute, Toronto, ON, Canada.Issue Date
2012-06
Metadata
Show full item recordAbstract
Breast cancer prevention with tamoxifen in high-risk women is limited due to concerns of endometrial cancer and thromboembolism. We report the risk of endometrial cancer, deep vein thrombosis and pulmonary embolism in women <50 years given tamoxifen for breast cancer prevention.Citation
Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review. 2012, 38 (4):318-28 Cancer Treat RevJournal
Cancer Treatment ReviewsDOI
10.1016/j.ctrv.2011.06.009PubMed ID
21775065Type
ArticleLanguage
enISSN
1532-1967ae974a485f413a2113503eed53cd6c53
10.1016/j.ctrv.2011.06.009